デフォルト表紙
市場調査レポート
商品コード
1763866

次世代シーケンシングサービス市場- 世界の産業規模、シェア、動向、機会、予測、サービス別、ワークフロー別、エンドユーザー別、地域別セグメント、競合、2020年~2030年

Next Generation Sequencing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Workflow, By End User, By Region and Competition, 2020-2030F


出版日
ページ情報
英文 180 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

次世代シーケンシングサービス市場- 世界の産業規模、シェア、動向、機会、予測、サービス別、ワークフロー別、エンドユーザー別、地域別セグメント、競合、2020年~2030年
出版日: 2025年06月30日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の次世代シーケンシング(NGS)サービス市場は、2024年に59億7,000万米ドルと評価され、予測期間中にCAGR 22.92%で成長し、2030年には205億9,000万米ドルに達すると予測されています。

この成長の背景には、ゲノム技術の急速な進歩、精密医療に対する需要の高まり、臨床研究におけるNGSの応用拡大、遺伝性疾患の有病率の増加があります。技術改良により、より高速で費用対効果の高いシーケンスプラットフォームが開発され、NGSが研究者や臨床医にとってより利用しやすくなっています。遺伝子プロファイリングに基づく個別化治療アプローチへの注目の高まりや、診断や臨床試験におけるNGSの統合は、ヘルスケアやライフサイエンス分野全体の需要をさらに押し上げています。

市場概要
予測期間 2026-2030
市場規模:2024年 59億7,000万米ドル
市場規模:2030年 205億9,000万米ドル
CAGR:2025年~2030年 22.92%
急成長セグメント データ分析
最大市場 北米

市場促進要因

個別化医療に対する需要の高まり

主な市場課題

高いコストとインフラ要件

主な市場動向

NGSデータ解析における人工知能の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の次世代シーケンシングサービス市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • サービス別(ヒトゲノムシーケンシングサービス、シングルセルシーケンシングサービス、微生物ゲノムベースシーケンシングサービス、遺伝子制御サービス、その他)
    • ワークフロー別(プレシーケンス、シーケンス、データ分析)
    • エンドユーザー別(病院・クリニック、学術・研究機関、製薬・バイオテクノロジー企業、その他)
    • 地域別
    • 企業別(2024)
  • 製品マップ
    • サービス別
    • ワークフロー別
    • エンドユーザー別
    • 地域別

第6章 北米の次世代シーケンシングサービス市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米:国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の次世代シーケンシングサービス市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の次世代シーケンシングサービス市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の次世代シーケンシングサービス市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの次世代シーケンシングサービス市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 世界の次世代シーケンシングサービス市場:SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Quest Diagnostics Inc.
  • Applied Biological Materials, Inc.
  • Novogene Co, Ltd.
  • Azenta Life Sciences(GENEWIZ)
  • NanoString Technologies, Inc.
  • Illumina, Inc.
  • PacBio, Inc.
  • Gene by Gene Ltd
  • Lucigen Corporation
  • ARUP Laboratories

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 15173

The Global Next Generation Sequencing (NGS) Services Market was valued at USD 5.97 billion in 2024 and is projected to reach USD 20.59 billion by 2030, growing at a CAGR of 22.92% during the forecast period. This growth is driven by rapid advancements in genomic technologies, rising demand for precision medicine, expanding applications of NGS in clinical research, and the increasing prevalence of genetic disorders. Technological improvements have led to faster and more cost-effective sequencing platforms, making NGS more accessible to researchers and clinicians. The growing focus on personalized treatment approaches based on genetic profiling and the integration of NGS in diagnostics and clinical trials are further boosting demand across healthcare and life science sectors.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.97 Billion
Market Size 2030USD 20.59 Billion
CAGR 2025-203022.92%
Fastest Growing SegmentData Analysis
Largest MarketNorth America

Key Market Drivers

Rising Demand for Personalized Medicine

The rising interest in personalized medicine is a major catalyst for the expansion of the NGS services market. Personalized medicine leverages genetic data to tailor medical care to individual patients, improving treatment effectiveness and disease management. NGS facilitates in-depth genomic analysis, helping identify mutations that influence disease risk and therapeutic responses.

Governments around the world are actively supporting this shift through large-scale initiatives. For instance, the U.S. National Institutes of Health's All of Us Research Program and the European Union's Horizon 2020 initiative have allocated substantial funding toward genomics research to promote personalized healthcare. These efforts underscore the central role of NGS in the evolving landscape of precision medicine.

Key Market Challenges

High Costs and Infrastructure Requirements

Despite the reduction in sequencing costs per genome, the overall financial burden of establishing and running NGS operations remains substantial. Setting up NGS laboratories demands significant investments in high-end equipment, computational systems, and trained personnel. Additionally, recurring costs for consumables, system maintenance, and data storage present ongoing challenges, particularly for facilities in developing nations.

The complexity of NGS workflows also requires continuous training and expertise, adding to operational overheads. These financial and technical barriers hinder the broader integration of NGS in low-resource settings. Although global programs-such as the Africa Pathogen Genomics Initiative-are working to expand infrastructure, disparities in access to NGS services persist.

Key Market Trends

Integration of Artificial Intelligence in NGS Data Analysis

The adoption of artificial intelligence (AI) and machine learning (ML) is emerging as a transformative trend in NGS services. Given the vast and complex nature of sequencing data, AI tools are increasingly essential for extracting meaningful insights. These technologies enhance pattern recognition, data interpretation, and predictive modeling in both clinical and research contexts.

In healthcare, AI-driven analysis supports accurate genetic diagnoses by identifying disease-associated variants and forecasting treatment responses. In research, AI facilitates discovery of novel biomarkers and therapeutic targets. Government-backed programs, such as those led by the U.S. NIH, are investing in AI-genomics integration, recognizing its potential to accelerate progress in personalized medicine and genomics-based research.

Key Market Players

  • Quest Diagnostics Inc.
  • Applied Biological Materials, Inc.
  • Novogene Co, Ltd.
  • Azenta Life Sciences (GENEWIZ)
  • NanoString Technologies, Inc.
  • Illumina, Inc.
  • PacBio, Inc.
  • Gene by Gene Ltd
  • Lucigen Corporation
  • ARUP Laboratories

Report Scope:

In this report, the Global Next Generation Sequencing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing Services Market, By Service:

  • Human Genome Sequencing Services
  • Single Cell Sequencing Services
  • Microbial Genome-based Sequencing Services
  • Gene Regulation Services
  • Others

Next Generation Sequencing Services Market, By Workflow:

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Next Generation Sequencing Services Market, By End User:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Others

Next Generation Sequencing Services Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Services Market.

Available Customizations:

Global Next Generation Sequencing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others)
    • 5.2.2. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
    • 5.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Map
    • 5.3.1. By Service
    • 5.3.2. By Workflow
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Next Generation Sequencing Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Workflow
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Workflow
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Workflow
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Workflow
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Workflow
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Next Generation Sequencing Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Workflow
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Next Generation Sequencing Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Workflow
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Workflow
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Workflow
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Workflow
        • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Workflow
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Workflow
        • 8.3.1.2.3. By End User
    • 8.3.2. India Next Generation Sequencing Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Workflow
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Next Generation Sequencing Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Workflow
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Workflow
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Workflow
        • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Workflow
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Workflow
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Next Generation Sequencing Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Workflow
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Next Generation Sequencing Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Workflow
        • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Workflow
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Next Generation Sequencing Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Workflow
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Workflow
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Next Generation Sequencing Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Workflow
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Next Generation Sequencing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Quest Diagnostics Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Applied Biological Materials, Inc.
  • 15.3. Novogene Co, Ltd.
  • 15.4. Azenta Life Sciences (GENEWIZ)
  • 15.5. NanoString Technologies, Inc.
  • 15.6. Illumina, Inc.
  • 15.7. PacBio, Inc.
  • 15.8. Gene by Gene Ltd
  • 15.9. Lucigen Corporation
  • 15.10. ARUP Laboratories

16. Strategic Recommendations

17. About Us & Disclaimer